Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
Source:
Nasdaq GlobeNewswire
/
20 Sep 2023 16:30:00 America/New_York
N/A
Share on,